Disturbances in the nodes of Ranvier are an early phenomenon in many CNS disorders, including the autoimmune demyelinating disease multiple sclerosis (MS). Using an animal model of optic neuritis, a common early symptom of MS, we have investigated nodal and paranodal compartments in the optic nerve during disease progression. Both nodes and paranodes, as identified by immunohistochemistry against sodium channels (Na v ) and Caspr, respectively, were observed to increase in length during the late induction phase of the disease, prior to onset of the demyelination and immune cell infiltration characteristic of optic neuritis. These changes were correlated with both axonal stress and microglial/macrophage activation, and were most apparent in the vicinity of the retrobulbar optic nerve head, the unmyelinated region of the optic nerve where retinal ganglion cell axons exit the retina. Using intravitreal glutamate injection as a model of a primary retinal insult, we demonstrate that this can induce similar nodal and paranodal changes. This may suggest that onset of neurodegeneration in the absence of demyelination, as reported in several studies into the nonaffected eyes of MS patients, may give rise to subtle disturbances in the axo-glial junction.
INTRODUCTION
Saltatory conduction of electrical signals along myelinated axons allows the rapid transmission of information. In the CNS, axons are myelinated by oligodendrocytes, with regularly spaced nodes of Ranvier between myelin sheaths where dense clustering of sodium channels allows signal propagation to occur. Here, the axonal membrane is able to contact the extracellular space and is surrounded by paranodal domains that serve as anchoring points for the myelinating loops of oligodendrocytes to the axon. The architecture of the nodes of Ranvier consists of specialized scaffolding and cell adhesion proteins, which are organized into distinct domains requiring correct assembly and maintenance for efficient action potential propagation (1) .
Increasingly, disturbances in nodal and paranodal domains are being recognized to occur under various conditions such as aging (2, 3) , as well as CNS disorders such as spinal cord compression (4, 5) , neonatal hyperoxia (6) , and Guillain-Barre syndrome (7, 8) . In multiple sclerosis (MS), similar changes have also been reported (9, 10) , and have been suggested to precede the onset of demyelination (10) . Similarly, studies with the animal model of MS, experimental autoimmune encephalomyelitis (EAE), also revealed axonal domain disruption in the spinal cord (11, 12) . Since paranodal axo-glial components are reported to be lost before nodal markers in these studies, it has been suggested that these changes may be a sensitive indicator of early myelin abnormalities in demyelinating disease (12) .
To date, alterations in the axo-glial junctions in optic neuritis have not been investigated. Optic neuritis is characterized by inflammatory demyelination of the optic nerve resulting in visual disturbances and neurodegeneration. As a common presenting symptom of MS (13) , it may reflect some of the earliest changes in the disease. In order to determine these early disease processes underlying optic neuritis, it can be modeled in rodents such as Brown Norway (BN) rats by immunization with myelin oligodendrocyte glycoprotein (MOG) (14) (15) (16) (17) (18) .
In this model, we have previously reported that neurodegenerative changes begin during the induction phase of the disease prior to inflammatory infiltration and demyelination (17, 18) . At this time, although demyelination and axonal loss are not yet detectable, microglial activation is already elevated in the optic nerve, and disturbances in both axonal and myelin ultrastructure are apparent (18) . In this study, we analyzed the distribution and structure of nodal and paranodal domains of the optic nerve during the development of autoimmune optic neuritis (AON). Although the density of these domains was unchanged, both the nodes and the paranodes began to elongate during the induction phase of AON correlating with both dephosphorylation of neurofilaments (indicative of axonal stress) and activation of microglia/macrophages. We also report that this is most apparent in the optic nerve head, and can be replicated by retinal injury, suggesting that primary neurodegeneration may give rise to these observations prior to onset of demyelination.
MATERIALS AND METHODS

Animals
Female BN rats (8-10 weeks of age; Charles River, Sulzfeld, Germany) were used in all experiments, and kept under environmentally controlled conditions in the absence of pathogens with ad libitum access to food and water. All experiments involving animal use were performed in compliance with the relevant laws and institutional guidelines of Baden Württemberg, Germany.
Induction and Evaluation of EAE
Rats were immunized by intradermal injection at the base of the tail with an emulsion (200 mL) containing 100 mg whole recombinant rat MOG (a kind gift of Prof Christine Stadelmann, Dept. of Neuropathology, University of Gottingen, Germany) in saline mixed 1:1 with complete Freund's adjuvant (Sigma-Aldrich; St. Louis, MO) containing 200 mg of heat-inactivated Mycobacterium tuberculosis H37RA (Difco Microbiology; Kansas). Rats were scored daily for the appearance of clinical symptoms associated with MOG-induced EAE, with clinical scoring as follows: Grade 0, no symptoms; grade 0.5, distal paresis of the tail; grade 1, complete tail paralysis; grade 1.5, paresis of the tail and mild hind limb paresis; grade 2.0, unilateral severe hind limb paresis; 2.5, bilateral severe hind limb paresis; grade 3.0, complete bilateral hind limb paralysis; grade 3.5, complete bilateral hind limb paralysis and paresis of 1 front limb; grade 4, complete paralysis (tetraplegia), moribund state, or death. For controls, shamimmunized rats (immunized with the same emulsion excluding MOG protein and taken at the same time-points as MOG immunized animals) and healthy, unimmunized rats were taken.
Primary Retinal Injury Model
In order to induce a primary retinal insult, BN rats were injected intravitreally with glutamate (n ¼ 4 rats). Animals were kept under anesthesia by inhalation of 3.5% isoflurane, and the eye was punctured at the cornea-sclera junction using a glass micropipette (tip diameter, 20 mm) connected to a 10-mL Hamilton syringe (Hamilton; Reno, NV) via a thin tube filled with mineral oil. In total, 100 nM of glutamate (4 mL of 25 mM glutamate in saline; Sigma-Aldrich) was injected slowly over the course of 5 minutes. Animals were maintained for 7 days following injection before further processing.
Tissue Preparation and Histology
Rats were killed by overdose intra peritoneal injection with ketamine (120 mg/kg) and xylazine (24 mg/kg) and transcardially perfused with 4% paraformaldehyde in phosphatebuffered saline (PBS). Optic nerves with eyes attached were dissected, cryoprotected by overnight incubation in 30% sucrose in PBS and then frozen in Cryoblock embedding medium (Medite; Burgdorf, Germany). Eight-micrometer-thick longitudinal sections were cut using a cryostat (Leica; Wetzlar, Germany), transferred to SuperFrost Plus microscope slides (Thermo Scientific; Waltham, MA) and stored at À20 C. Demyelination of optic nerves was assessed by Luxol fast blue (LFB) staining with hematoxylin counter staining. Neuronal apoptosis in the retina was assessed with the Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay using a previously described protocol (18) .
Immunohistochemistry
Antigen retrieval was performed for all antibodies on optic nerve sections by incubation in heated 0.2% citrate buffer (70-90 C) for 15 minutes. Sections (obtained from n ¼ 6 rats per healthy and MOG-immunized time-points and n ¼ 3 for sham-immunized time-points) were then blocked with 10% normal goat serum (Sigma-Aldrich) in 0.1% Triton X-100 in Tris-buffered saline (TBS-T) for 1 hour at room temperature (RT), before incubation in 0.1% TBS-T containing primary antibodies at 4 C overnight. 0 , 6-diamidino-2-phenylindole (DAPI). Microscopy and image acquisition was performed using a conventional Nikon Eclipse 80i microscope (Nikon; Shinagawa, Tokyo, Japan) and a LSM 700 confocal microscope (Zeiss; Jena, Germany).
Transmission Electron Microscopy
After perfusion with 1% paraformaldehyde/2.5% glutaraldehyde in PBS, optic nerves were dissected from rats (n ¼ 3 per time-point) and fixed in buffered isotonic 2% osmium tetroxide solution for 1 hour, followed by dehydration in ethanol and subsequent embedding in epoxy resin. Fifty-nanometerthick longitudinal sections were cut on an ultramicrotome (UtraCut R; Leica), and contrasting was performed with uranyl acetate/lead citrate. Images were then taken with an EM910 electron microscope (Zeiss) at 10 000x magnification.
Western Blot
Animals were killed using CO 2 , and optic nerves were removed and mechanically homogenized in ice-cold lysis buffer, (50 mM Tris HCl, 150 mM NaCl, and 1% Triton X-100) containing inhibitors (complete protease inhibitor cocktail; Roche Diagnostics GmbH, Mannheim, Germany) and protein concentration was determined (BCA assay; Pierce Chemical Co., Rockford, IL). Lysates were separated by reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis using 4%-20% gradient gels (Mini-PROTEAN TGX Stain-Free Precast gels; Bio-Rad, Hercules, CA). Protein was transferred to polyvinylidene difluoride membranes and blocked in either 5% milk powder or 5% BSA in 0.1% TBS-T for 1 hour at RT before incubation in primary antibodies against the following: Caspr (1:1000; Abcam), Contactin-1 (1:100; R&D Systems, Minneapolis, MN; Cat# AF904, RRID: AB_2292070), SMI32 (1:2000; Covance), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1: 2000, Millipore; Cat# MAB374, RRID: AB_2107445) in 5% milk powder or, for SMI32, in 5% BSA, with 0.1% TBS-T overnight at 4 C. Membranes were then washed and incubated with horseradish peroxidase-conjugated secondary antibodies (1:5000; Amersham, Buckinghamshire, UK) for 1 hour at RT, and proteins detected (ECL Prime Reagent; Amersham). Samples were subsequently normalized to the expression of GAPDH, and 4 or 5 samples per time point were used for quantification.
Image Analysis
Measurements of axonal structures and microglial distribution were quantified in a blinded manner using images acquired by confocal microscopy, using ZEN software (ZEN 2012 [black edition], Zeiss). Images were obtained at random positions along the optic nerve (using the DAPI filter channel to avoid bias towards staining intensity and appearance) unless where defined distances from the optic nerve head are given. For quantification, images were analyzed using the in-built measurement tools in Image J (NIH). For quantification of density and lengths of axonal domains, only complete structures (Na 
Statistics
All data are presented as their mean values 6 SEM. Statistical significance was assessed using SigmaPlot 13.0 (Systat Software GmbH; San Jose, CA). For comparing 2 experimental groups, statistical significance was assessed first for normalcy by Shapiro-Wilk test followed by either two-tailed Student's t-test (for normally distributed data) or by MannWhitney rank sum test (for not normally distributed data). One way analysis of variance (ANOVA) combined with Dunnett's method was used for comparing multiple experimental groups versus controls. A p value < 0.05 was considered to be significant. Correlations were calculated using the Pearson-Moment Correlation Coefficient using Sigma Plot.
RESULTS
Axonal Stress Begins Prior to Onset of AON
In order to confirm the timing of AON development, histopathological investigation of optic nerves was performed. The onset of AON typically occurs at the same time that MOGinduced EAE spinal cord symptoms become manifest, and is characterized by immune cell infiltration with concomitant demyelination (18) . Optic nerves were therefore investigated in healthy rats, rats at day 10 postimmunization (p.i.) just prior to onset of clinical AON (i.e. during the late induction phase), and on the first day of manifest EAE (day 1 EAE; average day of onset-day 14.9 6 0.4 p.i.). Sham-immunized rats served as further controls, and were analyzed at days 5, 7, 10, and 14 p.i. giving similar results. In agreement with our previous study (18) , there was no evidence of inflammatory demyelination (assessed by LFB staining) or immune cell infiltration (identified by hematoxylin-stained hypercellularity; Fig. 1C ), or axonal loss (assessed by immunostaining with SMI312 antibody, a pan neurofilament marker; Fig. 1G ) at day 10 p.i., as compared with healthy. With the onset of EAE, however, widespread demyelination and immune cell infiltration ( Fig. 1D ) and reduction of axonal density ( Fig. 1H ) was observed.
To assess the presence of axonal stress, longitudinal optic nerve sections were stained with SMI32, an antibody that recognizes nonphosphorylated neurofilaments (npNF). Their presence in normally myelinated axons is considered a sign of stress and as such they have been observed in MS lesions at various stages of their development (19) (20) (21) . In healthy optic nerves, SMI32 immunoreactivity was detected mainly on the unmyelinated nodal regions and only the occasional SMI32 þ axon could be detected ( Fig. 1I, M , p < 0.001 compared with healthy). The observed increase in npNF was confirmed by Western blotting. A statistically significant increase in npNF could be detected in optic nerve lysates at both day 10 p.i. and day 1 of EAE ( Fig. 1O) .
Axonal Domains Are Disrupted Prior to the Onset of Optic Neuritis
In order to assess the density of axonal nodes of Ranvier during AON, longitudinal optic nerve sections were stained with antibodies against Caspr and Na v , major protein constitutes of axonal paranodal and nodal domains, respectively ( Fig. 2A-E) . Only complete axonal domains consisting of Na v þ nodes flanked by Caspr þ paranodes from both sides were counted. There was no significant difference in the numbers of axonal domains between healthy (Fig. 2F, 7317 .3 6 356.9 axonal domains per mm 2 ) and optic nerves from animals during the induction phase (day 10 p.i. 6344.9 6 268.9; p ¼ 0.09). Upon development of EAE, a substantial reduction in the numbers of axonal domains could be observed. On day 1 of EAE (the onset of the clinical phase of the disease), the number of axonal domains were reduced to 50.1% of healthy values (day 1 EAE, 3667.6 6 334.9; p < 0.001 compared with healthy and sham). As disease progressed, this effect became more pronounced where only one third (33.3%) of the healthy value could be detected (day 4 EAE, 2433.8 6 303.5; p < 0.001 compared with healthy and sham). The observed reduction in the number of nodes of Ranvier was accompanied by the loss of major axonal paranodal proteins in optic nerve lysates. Significant reduction of Caspr (Fig. 2G, H (Fig. 2G, I ; day 1 EAE and day 8 of EAE p < 0.001 compared with healthy and sham) protein levels, axonal cell adhesion molecules required for anchoring to oligodendrocyte neurofascin at paranodes, were detected from the onset of the clinical phase of the disease by Western blotting. In light of studies reporting a switch in Na v isoforms from Na v 1.6 to Na v 1.2 in acute MS plaques (22) and during optic neuritis (23), presumably to restore conduction in demyelinated axons, we investigated expression of these Na v isoforms. Na v 1.6 þ nodes were observed at all time-points investigated ( Fig. 2J-L) , but Nav1.2 was absent ( Fig. 2M-O) , with the hypothalamus serving as control tissue due to reports of magnocellular neurons expressing Na v 1.2 (24) . Thus, no change in Na v isoforms were observed during the time-course of AON investigated. We believe that the disease time frame investigated in this study is probably too short for this adaptive switch to occur since we only looked at one day after demyelination has begun, and have focused in this study on nodal changes occurring prior to demyelination.
Next, structural changes in axonal domains were assessed throughout the time course of AON. In healthy optic nerves, axonal domains appeared as dense clusters of Na V flanked by compact Caspr þ paranodes (Fig. 3A) . At the late stage of the induction phase (day 10 p.i.) a substantial proportion of domains appeared with altered architecture. Both the Na V þ nodal gap and Caspr þ paranodes had elongated profiles (Fig. 3B) . With onset of the clinical phase (day 1 EAE) this became more pronounced, with some axons also having swollen paranodal domains (Fig. 3C) . Measurement of the length of both Na V þ nodal and Caspr þ paranodal domains throughout the course of EAE revealed statistically significant elongation in both compartments starting from day 10 p.i., and continuing as EAE progressed ( Fig. 3D-H ; Table) .
In order to analyze the ultrastructure of the axonal domains, electron microscopy was employed confirming the immunohistochemical analysis regarding elongation. In healthy animals, myelinating loops of oligodendrocytes were tightly anchored to the paranodal regions of the axon, which were separated by an unmyelinated nodal gap (Fig. 3J) . At day 10 p.i., although axons were still myelinated, subtle changes could also be detected with detachment of myelinating loops from the paranodal domains and a widening of the nodal gap on some axons (Fig. 3K) . Following the onset of EAE, paranodal regions were found with clear signs of pathology characterized by the loss of a well-defined paranodal region, further widening of the nodal gap and vacuolization of both periaxonal and axonal compartments (Fig. 3L) . Quantification of the nodal gap from electron microscopic images confirmed the findings from conventional immunohistochemistry, with significant elevation in nodal lengths being seen at day 10 p.i compared with both healthy and sham controls (Fig. 3I ).
Nodal and Paranodal Changes Correlate With Axonal Stress
Next, we investigated a possible relationship between the disruption of axonal domains and the increased axonal stress we observed during the late induction phase of AON (day 10 p.i., Fig. 1K, M) . Upon comparing the lengths of Caspr þ paranodes associated with SMI32 þ and SMI32 -axons at day 10 p.i., the average paranodal length was increased on SMI32 þ axons at 4.94 6 0.04 mm (ranging from 2.98 to 9.86 mm), compared with SMI32 -axons at 3.28 6 0.02 mm (ranging from 2.04 to 5.26 mm, p < 0.001; Fig. 4A, B) . The average length of Caspr þ paranodes not associated with SMI32 þ immunoreactivity was comparable to that found in healthy optic nerves (3.23 6 0.08 lm; Fig. 3E ). Following the onset of the clinical phase and inflammatory demyelination of the optic nerve, axonal domains were completely disrupted with only traces of Caspr immunoreactivity detectable on SMI32 þ stressed axons (Fig. 4C) . Following demyelination, and in the absence of paranodal regions, Na V immunoreactivity became dispersed along naked axons (Fig. 4D) .
Disruption of Axonal Domain Architecture Correlates With Microglial/Macrophage Activation and Distance From the Optic Nerve Head
The induction phase of AON/EAE is characterized by the absence of parenchymal infiltration of immune cells, however, we have reported an increase in the numbers of FIGURE 2. Continued taken at (C) day 10 p.i. (induction phase of EAE), (D) day 1 EAE and (E) day 4 EAE (early and late stages of the clinical phase of EAE, respectively). (F) A significant reduction in axonal domains was observed at day 1 EAE, n ¼ 6 for healthy and MOGimmunized animals and n ¼ 3 for sham-immunized. (G) Representative Western blots incubated with antibodies against Caspr (180 kDa), Contactin-1 (118 kDa) and GAPDH (38 kDa). Quantification of Western blots revealed statistically significant decreases in both (H) Caspr and (I) Contactin-1 at day 1 EAE, n ¼ 5 samples per time point. Immunohistochemistry of optic nerve sections with antibodies against Nav1.6 (J-L, green) or Nav1.2 (M-O, green) sodium channel subunits revealed Nav1.6 þ nodes to be visible throughout the disease course, whereas no immuno-labeling was seen for Nav1.2. Counterstaining was performed with antipan Neurofascin antibody (panNfasc, red, to label both paranodal and nodal domains) and DAPI (blue). As a positive control for Nav.1.2, the periventricular hypothalamus was also labeled (P) with SMI32 (red, to identify [unmyelinated] axons) and DAPI (blue) counter-staining. *p < 0.05 and **p < 0.01 compared with healthy, 
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Axonal Domains in Optic Neuritis ED1 þ cells, which based on morphology are hypothesized to be resident activated microglia, in both the retina and the optic nerve (18) . These cells have a specific spatial distribution in the optic nerve with high numbers of ED1 þ microglia/macrophages in the vicinity of the optic nerve head, and decreasing frequency with increased distance from this region. In order to determine any correlation between the presence of ED1 þ cells and paranodal elongation, Na V þ nodes and Caspr þ paranodes were visualized on longitudinal optic nerve sections taken from rats at day 10 p.i., and images were taken at defined distances from the optic nerve head as indicated in Figure 5 (A-C). Interestingly, Na v þ nodes and Caspr þ paranodes nodes were longest towards the optic nerve head, with more elongated nodes and paranodes within 1 mm of the optic nerve head, compared with more distal positions (Fig. 5D) . Costaining with ED1 to label activated microglia/macrophages confirmed that at this time-point (day 10 p.i.), the highest number of ED1 þ cells were located towards the optic nerve head (Fig. 5E) .
Additionally, there was a positive linear correlation between the distribution of ED1 þ cells and the lengths of Caspr þ paranodes ( Fig. 5F ; R ¼ 0.707, p < 0.001). Since the correlation of Caspr þ paranodal length and the density of activated microglia/macrophages might just reflect their common relationship with the distance from the optic nerve head, a more direct relationship between these 2 observations was made by examining paranodal lengths in the close vicinity of microglia in the late induction phase (day 10 p.i.). The length of paranodal domains was measured within a 20-mm radius of ED1 þ cells and compared with the length of paranodal domains which were not associated with activated microglia/macrophages (Fig. 5G) . It could not be excluded that there might be ED1 þ cells within 20 mm in the z-axis but, through the use of confocal microscopy and the generation of 8-mm-thick z-stack images, we hoped to minimize this possibility. There was a statistically significant difference between the lengths of paranodes within 20 mm of ED1 þ cells (3.50 6 0.02 mm, lengths ranging from 1.72 to 7.11 mm, p < 0.001) compared with those at greater distances (2.87 6 0.02 mm, ranging from 1.60 to 5.56 mm; Fig. 5H ).
Induction of a Retinal Insult Replicates Axonal Domain Disturbances
Since we saw changes in the nodal lengths, in addition to the paranode, which has not been reported in other cases of autoimmune inflammatory disease (MS brains and EAE spinal cords [9, 12] ), we wondered whether disease processes unique to our model might explain this difference. Whereas autoimmune attack of the myelin is traditionally understood to underlie MS pathophysiology, in cases of optic neuritis, retinal neurodegeneration can be observed in MS patients in the absence of inflammatory infiltration and demyelination of the optic nerve (25) (26) (27) (28) (29) , and is also modeled in AON (17, 18) . Therefore, we wished to determine whether a retinal insult to induce optic nerve neurodegeneration would replicate our findings.
To induce neurodegeneration within the retina, we injected glutamate into the vitreous body, which is known to result in degeneration of retinal ganglion cells, the neurons whose axons make up the optic nerve (30) (31) (32) . Seven days following intravitreal injection of glutamate, TUNEL þ apoptotic cells could be observed in both the ganglion cell and inner nuclear layers of the retina (Fig. 6C) , accompanied by a significant increase in the numbers of ED1 þ microglia/macrophages in both the retina (Fig. 6F, P) and optic nerve (Fig. 6I) . Similarly to AON, this increase was most predominant within the optic nerve head and proximal segments of the nerve (Fig. 6Q) . No other macroscopic signs of optic nerve injury, such as demyelination and axonal swellings/transections, could be detected in the optic nerve following the primary retinal injury (data not shown), apart from a significant increase in the number of SMI32 þ axons (Fig. 6L, R ; 367.8 6 33.7 SMI32 þ axons/mm 2 , p< 0.001 compared with healthy). Again, this was similar to that observed at day 10 p.i. of AON.
Next, immunostaining to visualize Na v þ and Caspr þ domains (Fig. 6O ) revealed elongation of both nodal and paranodal domains in the optic nerves of rats receiving intravitreal glutamate injections similar to that observed at day 10 p.i. of AON ( Fig. 6S, T ; average nodal length 1.56 6 0.03, mm, p < 0.001; paranodal length 3.57 6 0.06 mm, p ¼ 0.009 compared with healthy).
DISCUSSION
Axonal domains have specialized molecular architecture to ensure proper saltatory conduction, which is of particular importance in long axons, such as those comprising the optic nerve (33, 34) . However, under pathophysiological conditions, these domains can become disrupted (1) as has been documented in Guillain-Barre syndrome (7, 35) , spinal cord compression (4, 5), aging (2, 3) and MS (9, 10). Here we report that during the preclinical phase of AON, prior to inflammatory cell infiltration and demyelination, elongation of both paranodal and nodal axonal domains within the optic nerve occurs. This correlated with increased stress of the axons, as indicated by dephosphorylation of neurofilaments, and the presence of activated microglia.
Similar observations have been made in both MS brains (10) and EAE spinal cords (12) , where paranodal elongations have been identified in normal-appearing white matter, also associated with SMI32 þ axons, and therefore proposed to be an initiating step in the process of demyelination. This is also supported by the association of these disturbances with activated microglia, which in the absence of inflammatory infiltration characterizes the "preactive lesion" (36) . Within areas of active demyelination, demyelinated MS lesion centers lacked paranodal domains with nodal Na v being diffusely þ axons in the optic nerve. Quantification of the length of (S) Na V þ nodes and (T) Caspr þ paranodes in optic nerves from healthy rats, day 10 post MOG immunization, and following intravitreal glutamate injection. n ¼ 6 retinas/optic nerves per group. **p < 0.01, ANOVA. Scale bars: C, F, I, L ¼ 50 mm; O ¼ 5 mm. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. distributed along naked axons, whereas on the edge of the inflammatory lesion, where axons were still myelinated, paranodes were lengthened whereas the nodes were not (9, 10) . This led to the conclusion that paranodal changes may be more sensitive than nodal ones (10) .
In our study, however, we also saw disturbances in the nodal domain which was significantly elongated already by day 10 p.i. Since our disease model involves a neurodegenerative component in addition to myelin degeneracy, we hypothesize that a loss in axonal anchoring may underlie this observation. This is supported by observations in a rat model of Guillain-Barre disease where immunization with a neuritogenic P2 peptide resulted in significant nodal but not paranodal lengthening (7) . To test this, we induced a retinal insult by intravitreal injection of glutamate, previously shown to induce widespread neurodegeneration within the retina (30) (31) (32) , as confirmed by TUNEL staining. Similar to that seen during AON, following retinal injury, both nodal and paranodal elongations were observed upstream in the optic nerve.
Possible causes of the axonal domain changes reported here in AON include microglial activity, autoantibody responses against myelin, and disturbances to the axonal cytoskeleton. In the absence of demyelination, microglia are known to make major contributions to axonal injury both in normal-appearing white matter (37, 38) and in grey matter lesions (39, 40) of MS patients. A contribution of activated microglia to paranodal alterations have been suggested, and treatment of EAE mice with minocycline resulted in a reduction in both paranodal disruption and the density of activated microglia (12) . However, since minocycline, as the authors state, is "a potent inhibitor of systemic and CNS inflammation," it is hard to determine whether treatment was reducing microglial influence on nodal parameters or whether both were reduced as a result of the widespread effects of minocycline treatment. In AON, the role of early activated microglia is similarly unclear, and whether the correlation of disrupted paranodal domains with distance from activated microglia reflects a causal relationship or a similar response to an as yet unidentified insult remains to be clarified.
Autoantibodies, which are a prominent part of MOGinduced EAE in BN rats (15, 18) , may also be involved. In models of Guillain-Barre disease, a role for autoantibodies against oligodendrocyte and axonal epitopes has been suggested (7, 8) . Whether antiMOG antibodies, as present in AON, can induce such alterations in the nodal/paranodal compartments is not clear, but 1 possible candidate is antineurofascin antibodies, reported to arise following MOGimmunization through epitope spreading (41) . Such antibodies have also been detected in MS patients (42) . Despite the intriguing fact that MOG-immunization can lead to antibodies targeting a major component of the nodes of Ranvier, the timing required for epitope spreading to occur (significant antineurofascin antibody levels were not detected in immunized Dark Agouti rats until $26-41 days p.i. (41)), means that this is unlikely to underlie the early preclinical changes we report here.
Finally, disturbances to the axonal cytoskeleton may influence nodal/paranodal alterations. Both nodal Na v and paranodal Contactin-1/Caspr complexes are stabilized in the axonal membrane through their interconnection with the actin skeleton, mediated through proteins such as ankyrin and spectrin (43, 44) , with an essential role for axonal bII spectrin having been demonstrated for paranode-dependent clustering of Na v channels (45) . We have previously observed disturbances in axonal ultrastructure in preclinical AON (18) , which occurred at the same time-point as increases in optic nerve calcium and subsequent calpain-mediated degradation of spectrin (46) . Other studies have demonstrated that increased axonal calcium levels and calpain activity can lead to axonal domain disruption under various pathological conditions and, importantly, pharmacological inhibition of calpain leads to their preservation (5, 8, 11, (47) (48) (49) . Again, due to the neurodegenerative component observed in preclinical AON that was replicated by intravitreal injection of glutamate, this may well be a contributory factor in the nodal and paranodal observations that we report here.
In conclusion, we corroborate previous reports that nodal/paranodal disturbances may be an early marker of cellular stress that precede the onset of demyelination in autoimmune demyelinating disease. This was particularly apparent in the optic nerve head, where we have previously seen early evidence of pathophysiological changes such as microglial activation and antibody deposition (18) , possibly resulting from the partially permeable nature of its vasculature (50, 51) . In light of studies into the relationship of normal-appearing white matter injury with more distally located lesions (52), we provide evidence that upstream induction of neurodegeneration, such as in the retina, can result in similar downstream events such as microglial activation and architectural disturbances in the nodes of Ranvier.
